CSE endorses ICMJE principles on OA to drug trial data

The Council of Science Editors has endorsed the principles on clinical drug trial data promulgated by the International Committee of Medical Journal Editors (ICMJE). Unfortunately, the article saying so, in the July/Augusgt issue of Science Editor, is only accessible to subscribers, at least so far.

The ICMJE principles essentially say that journal editors should refuse to publish articles on new drugs unless the underlying clinical trial data are on deposit in an OA database independent of the drug manufacturer.